Flavio Vincenti, MD

Professor

I have been at UCSF since 1975 and on the faculty of the Department of Medicine in the division of Nephrology since 1976 and have been involved with the transplant service in patient care and clinical trials with novel immunosuppression drugs

Publications

  1. Chandran S, Vincenti F. Antiplasma cell antibodies: A new era of human leukocyte antigen antibody control in solid organ transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2024. PMID: 39384021


  2. Torija A, Marie M, Flavio V, Casanova-Ferrer F, Caroline P, Tambur AR, Donadeu L, Crespo E, Kervella D, Meneghini M, Torres IB, Hafkamp F, Martinez-Lacalle A, Carrera C, Zúñiga J, Brar A, Cruzado J, Gaber AO, Lee H, Montgomery RA, Stegall M, Carmagnat M, Usureau C, Moreso F, Grimbert P, Bestard O. Anti-HLA serological response to CD38-targeting desensitization therapy is challenged by peripheral memory B-cells in highly sensitized kidney transplant candidates. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2024. PMID: 39134120


  3. Mannon RB, Vincenti F. Poised for Innovation: Considerations for End Points for New Drug Development in Kidney Transplantation. Journal of the American Society of Nephrology : JASN 2024. PMID: 39102302


  4. Larsen CP, Vincenti F, D Kou T, Shadur CA, Bresnahan B, Jordan SC, Woodle ES, Goes N, Vella J, Wojciechowski D, Polinsky MS, Gomez-Caminero A. Long-term Safety in Epstein-Barr Virus-Seropositive Kidney-only Transplant Recipients Treated With Belatacept in Clinical Practice: Final Study Results From the ENLiST Registry. Transplantation direct 2024. PMID: 38769981


  5. Vincenti F, Bromberg J, Kim J, Faravardeh A, Leca N, Alperovich G, Csomor PA, Aslam S, Neylan J. The hepatocyte growth factor mimetic, ANG-3777, in kidney transplant recipients with delayed graft function: results from a randomized phase 3 trial. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2024. PMID: 38387622


  6. Vincenti F, Bestard O, Brar A, Cruzado JM, Seron D, Gaber AO, Ali N, Tambur AR, Lee H, Abbadessa G, Paul JA, Dudek M, Siegel RJ, Torija A, Semiond D, Lépine L, Ternes N, Montgomery RA, Stegall M. Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant. Journal of the American Society of Nephrology : JASN 2023. PMID: 38147137


  7. Vincenti F, Angeletti A, Ghiggeri GM. State of the art in childhood nephrotic syndrome: concrete discoveries and unmet needs. Frontiers in immunology 2023. PMID: 37503337


  8. Limaye AP, Budde K, Humar A, Vincenti F, Kuypers DRJ, Carroll RP, Stauffer N, Murata Y, Strizki JM, Teal VL, Gilbert CL, Haber BA. Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial. JAMA 2023. PMID: 37279999


  9. Duan M, Nguyen DC, Joyner CJ, Saney CL, Tipton CM, Andrews J, Lonial S, Kim C, Hentenaar I, Kosters A, Ghosn E, Jackson A, Knechtle S, Maruthamuthu S, Chandran S, Martin T, Rajalingam R, Vincenti F, Breeden C, Sanz I, Gibson G, Lee FE. Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses. Cell reports 2023. PMID: 37355988


  10. Vincenti F, Budde K, Grinyo J, Rostaing L, Kirk AD, Larsen CP. Open letter to Bristol Myers Squibb: belatacept; we aren't done yet. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2023. PMID: 37394381


  11. Raynaud M, Al-Awadhi S, Juric I, Divard G, Lombardi Y, Basic-Jukic N, Aubert O, Dubourg L, Masson I, Mariat C, Prié D, Pernin V, Le Quintrec M, Larson TS, Stegall MD, Bikbov B, Ruggenenti P, Mesnard L, Ibrahim HN, Nielsen MB, Matas AJ, Nankivell BJ, Benjamens S, Pol RA, Bakker SJL, Jouven X, Legendre C, Kamar N, Smith BH, Wadei HM, Durrbach A, Vincenti F, Remuzzi G, Lefaucheur C, Bentall AJ, Loupy A. Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation study. BMJ (Clinical research ed.) 2023. PMID: 37257905


  12. Rashmi P, Sigdel TK, Rychkov D, Damm I, Da Silva AA, Vincenti F, Lourenco AL, Craik CS, Reiser J, Sarwal MM. Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factors. Annals of translational medicine 2023. PMID: 37404982


  13. Duan M, Nguyen DC, Joyner CJ, Saney CL, Tipton CM, Andrews J, Lonial S, Kim C, Hentenaar I, Kosters A, Ghosn E, Jackson A, Knechtle S, Maruthamuthu S, Chandran S, Martin T, Rajalingam R, Vincenti F, Breeden C, Sanz I, Gibson G, Eun-Hyung Lee F. Human Bone Marrow Plasma Cell Atlas: Maturation and Survival Pathways Unraveled by Single Cell Analyses. bioRxiv : the preprint server for biology 2023. PMID: 36711623


  14. Raval AD, Kistler KD, Tang Y, Vincenti F. Burden of neutropenia and leukopenia among adult kidney transplant recipients: A systematic literature review of observational studies. Transplant infectious disease : an official journal of the Transplantation Society 2022. PMID: 36508475


  15. Looney CM, Schroeder A, Tavares E, Garg J, Schindler T, Vincenti F, Redfield RR, Jordan SC, Busque S, Woodle ES, Khan J, Eastham J, Micallef S, Austin CD, Morimoto A. Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients. Transplantation direct 2023. PMID: 36700064


  16. Hricik D, Armstrong B, Alhamad T, Brennan D, Bromberg J, Bunnapradist S, Chandran S, Fairchild R, Foley D, Formica R, Gibson I, Kesler K, Kim SJ, Mannon R, Menon M, Newell K, Nickerson P, Odim J, Poggio E, Sung R, Shapiro R, Tinckam K, Vincenti F, Heeger P. Infliximab Induction Lacks Efficacy and Increases BK Virus Infection in Deceased Donor Kidney Transplant Recipients. Journal of the American Society of Nephrology : JASN 2022. PMID: 36195441


  17. Brar S, Berry R, Raval AD, Tang Y, Vincenti F, Skartsis N. Outcomes among CMV-mismatched and highly sensitized kidney transplants recipients who develop neutropenia. 2022. PMID: 34984735


  18. Skartsis N, Peng Y, Ferreira LMR, Nguyen V, Ronin E, Muller YD, Vincenti F, Tang Q. IL-6 and TNFa Drive Extensive Proliferation of Human Tregs Without Compromising Their Lineage Stability or Function. 2021. PMID: 35003100


  19. Budde K, Prashar R, Haller H, Rial M, Kamar N, Agarwal A, de Fijter J, Rostaing L, Berger S, Djamali A, Leca N, Allamassey L, Gao S, Polinsky M, Vincenti F. Conversion from Calcineurin Inhibitor to Belatacept-based Maintenance Immunosuppression in Renal Transplant Recipients: a Randomized Phase 3b Trial. 2021. PMID: 34706967


  20. Aubert O, Divard G, Pascual J, Oppenheimer F, Sommerer C, Citterio F, Tedesco H, Chadban S, Henry M, Vincenti F, Srinivas T, Watarai Y, Legendre C, Bernhardt P, Loupy A. Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study. 2021. PMID: 34620664


  21. Danovitch GM, Bunnapradist S, Cohen D, Hariharan S, McKay D, Ratner L, Stegall MD, Steiner RW, Stock PG, Vincenti F. Tests for the noninvasive diagnosis of kidney transplant rejection should be evaluated by kidney transplant programs. 2021. PMID: 34080294


  22. Lee LM, Zhang H, Lee K, Liang H, Merleev A, Vincenti F, Maverakis E, Thomson AW, Tang Q. A Comparison of Ex Vivo Expanded Human Regulatory T Cells Using Allogeneic Stimulated B Cells or Monocyte-Derived Dendritic Cells. 2021. PMID: 34220826


  23. Chandran S, Leung J, Hu C, Laszik ZG, Tang Q, Vincenti FG. Interleukin-6 Blockade with Tocilizumab Increases Tregs and Reduces T Effector Cytokines in Renal Graft Inflammation: A Randomized Controlled Trial. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2020. PMID: 33331082


  24. Zarinsefat A, Hartoularos G, Rychkov D, Rashmi P, Chandran S, Vincenti F, Yee CJ, Sarwal MM. Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation. Frontiers in genetics 2021. PMID: 33469465


  25. Kirk AD, Adams AB, Durrbach A, Ford ML, Hildeman DA, Larsen CP, Vincenti F, Wojciechowski D, Woodle ES. Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2020. PMID: 33128812


  26. Vincenti F, Kim J, Gouveia D, Pelle G, Mayne TJ, Neylan JF. Phase 3 trial Design of the Hepatocyte Growth Factor Mimetic ANG-3777 in Renal Transplant Recipients With Delayed Graft Function. Kidney international reports 2020. PMID: 33615054


  27. Dobi D, Vincenti F, Chandran S, Greenland JR, Bowman C, Chen A, Henrik J, Laszik ZG. The impact of belatacept on the phenotypic heterogeneity of renal T cell-mediated alloimmune response: the critical role of maintenance treatment and inflammatory load. Clinical transplantation 2020. PMID: 32939817


  28. Zarinsefat A, Hartoularos G, Chandran S, Yee CJ, Vincenti F, Sarwal MM. Single-cell RNA sequencing of Tocilizumab-treated peripheral blood mononuclear cells as an in vitro model of inflammation. bioRxiv : the preprint server for biology 2020. PMID: 32935096


  29. Yang JYC, Sarwal RD, Sigdel TK, Damm I, Rosenbaum B, Liberto JM, Chan-On C, Arreola-Guerra JM, Alberu J, Vincenti F, Sarwal MM. A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection. Science translational medicine 2020. PMID: 32188722


  30. Harel E, Shoji J, Abraham V, Miller L, Laszik ZG, King A, Dobi D, Szabo G, Hann B, Sarwal MM, Craik CS, Vincenti F. Further Evidence that the Soluble Urokinase Plasminogen Activator Receptor Does Not Directly Injure Mice or Human Podocytes. Transplantation 2019. PMID: 31449183


  31. Sigdel T, Nguyen M, Liberto J, Dobi D, Junger H, Vincenti F, Laszik Z, Sarwal MM. Assessment of 19 Genes and Validation of CRM Gene Panel for Quantitative Transcriptional Analysis of Molecular Rejection and Inflammation in Archival Kidney Transplant Biopsies. Frontiers in medicine 2019. PMID: 31632976


  32. Vincenti F, Klintmalm G, Yang H, Peddi VR, Blahunka P, Conkle A, Santos V, Holman J. A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti-CD40 monoclonal antibody, in kidney transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2019. PMID: 31397943


  33. Pascual J, Berger SP, Chadban SJ, Citterio F, Kamar N, Hesselink DA, Legendre C, Eisenberger U, Oppenheimer F, Russ GR, Sommerer C, Rigotti P, Srinivas TR, Watarai Y, Henry ML, Vincenti F, Tedesco-Silva H. Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients. Transplantation reviews (Orlando, Fla.) 2019. PMID: 31377099


  34. Redfield RR, Jordan SC, Busque S, Vincenti F, Woodle ES, Desai N, Reed EF, Tremblay S, Zachary AA, Vo AA, Formica R, Schindler T, Tran H, Looney C, Jamois C, Green C, Morimoto A, Rajwanshi R, Schroeder A, Cascino MD, Brunetta P, Borie D. Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2019. PMID: 31257724


  35. Berger SP, Sommerer C, Witzke O, Tedesco H, Chadban S, Mulgaonkar S, Qazi Y, de Fijter JW, Oppenheimer F, Cruzado JM, Watarai Y, Massari P, Legendre C, Citterio F, Henry M, Srinivas TR, Vincenti F, Hernandez Gutierrez MP, Marti AM, Bernhardt P, Pascual J. Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from TRANSFORM study. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2019. PMID: 31152476


  36. Pineda S, Sigdel TK, Liberto JM, Vincenti F, Sirota M, Sarwal MM. Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing. Nature communications 2019. PMID: 31015506


  37. Harel E, Shoji J, Abraham V, Miller L, Laszik Z, Thurison T, King A, Olshen A, Leung J, Szabo G, Hann B, Høyer-Hansen G, Craik CS, Vincenti F. Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation. Clinical transplantation 2019. PMID: 30689221


  38. Busque S, Vincenti FG, Tedesco Silva H, O'Connell PJ, Yoshida A, Friedewald JJ, Steinberg SM, Budde K, Broeders EN, Kim YS, Hahn CM, Li H, Chan G. Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial. Transplantation direct 2018. PMID: 30234149


  39. Webber AB, Tatapudi V, Maw TT, Peralta C, Leung JCY, Vincenti F. Nuclear Factor of Activated T Cell-regulated Cytokine Gene Expression for Adjustment of Tacrolimus in Kidney Transplant Recipients: A Randomized Controlled Pilot Trial. Transplantation direct 2018. PMID: 30046659


  40. Vincenti F, Budde K, Merville P, Shihab F, Ram Peddi V, Shah M, Wyburn K, Cassuto-Viguier E, Weidemann A, Lee M, Flegel T, Erdman J, Wang X, Lademacher C. A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2018. PMID: 29745007


  41. Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F. Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation. Journal of the American Society of Nephrology : JASN 2018. PMID: 29752413


  42. Florman S, Vincenti F, Durrbach A, Abouljoud M, Bresnahan B, Garcia VD, Mulloy L, Rice K, Rostaing L, Zayas C, Calderon K, Meier-Kriesche U, Polinsky M, Yang L, Medina Pestana J, Larsen CP. Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients administered belatacept or cyclosporine in BENEFIT and BENEFIT-EXT. Clinical transplantation 2018. PMID: 29461660


  43. Sigdel TK, Nguyen M, Dobi D, Hsieh SC, Liberto JM, Vincenti F, Sarwal MM, Laszik Z. Targeted Transcriptional Profiling of Kidney Transplant Biopsies. Kidney international reports 2018. PMID: 29854981


  44. Wojciechowski D, Chandran S, Webber A, Hirose R, Vincenti F. Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients. Transplantation proceedings 2017. PMID: 28923623


  45. Vincenti F, Blancho G, Durrbach A, Grannas G, Grinyó J, Meier-Kriesche HU, Polinsky M, Yang L, Larsen CP. Ten-year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4-weekly or 8-weekly. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2017. PMID: 28758341


  46. Chandran S, Tang Q, Sarwal M, Laszik ZG, Putnam AL, Lee K, Leung J, Nguyen V, Sigdel T, Tavares EC, Yang JYC, Hellerstein M, Fitch M, Bluestone JA, Vincenti F. Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2017. PMID: 28675676


  47. Wojciechowski D, Chandran S, Yang JYC, Sarwal MM, Vincenti F. Retrospective evaluation of the efficacy and safety of belatacept with thymoglobulin induction and maintenance everolimus: A single-center clinical experience. Clinical transplantation 2017. PMID: 28662293


  48. Tang Q, Vincenti F. Transplant trials with Tregs: perils and promises. The Journal of clinical investigation 2017. PMID: 28665300


  49. Asare A, Kanaparthi S, Lim N, Phippard D, Vincenti F, Friedewald J, Pavlakis M, Poggio E, Heeger P, Mannon R, Burrell BE, Morrison Y, Bridges N, Sanz I, Chandraker A, Newell KA, Turka LA. B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2017. PMID: 28371372


  50. Vincenti F, Fervenza FC, Campbell KN, Diaz M, Gesualdo L, Nelson P, Praga M, Radhakrishnan J, Sellin L, Singh A, Thornley-Brown D, Veronese FV, Accomando B, Engstrand S, Ledbetter S, Lin J, Neylan J, Tumlin J. A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis. Kidney international reports 2017. PMID: 29270487


  51. Vincenti F. Belatacept: the challenges with transformational drugs. Translational andrology and urology 2017. PMID: 28540252


  52. Wojciechowski D, Chandran S, Vincenti F. Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients. Clinical transplantation 2017. PMID: 28190259


  53. Grinyó JM, Del Carmen Rial M, Alberu J, Steinberg SM, Manfro RC, Nainan G, Vincenti F, Jones-Burton C, Kamar N. Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial. American journal of kidney diseases : the official journal of the National Kidney Foundation 2016. PMID: 27889299


  54. Wojciechowski D, Vincenti F. Current status of costimulatory blockade in renal transplantation. Current opinion in nephrology and hypertension 2016. PMID: 27517137


  55. Wojciechowski D, Vincenti F. Costimulatory Blockade and Use of mTOR Inhibitors: Avoiding Injury Part 2. Advances in chronic kidney disease 2016. PMID: 27742385


  56. Klintmalm GB, Vincenti F, Kirk A. Steroid-Responsive Acute Rejection Should Not Be the End Point for Immunosuppressive Trials. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2016. PMID: 27232598


  57. Vincenti F. Belatacept and Long-Term Outcomes in Kidney Transplantation. The New England journal of medicine 2016. PMID: 27355541


  58. Webber AB, Vincenti F. An Update on Calcineurin Inhibitor-Free Regimens: The Need Persists, but the Landscape has Changed. Transplantation 2016. PMID: 27003097


  59. Vincenti F, Rostaing L, Grinyo J, Rice K, Steinberg S, Gaite L, Moal MC, Mondragon-Ramirez GA, Kothari J, Polinsky MS, Meier-Kriesche HU, Munier S, Larsen CP. Belatacept and Long-Term Outcomes in Kidney Transplantation. The New England journal of medicine 2016. PMID: 26816011


  60. Wolf M, Weir MR, Kopyt N, Mannon RB, Von Visger J, Deng H, Yue S, Vincenti F. A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation. Transplantation 2016. PMID: 26177089


  61. Sigdel TK, Bestard O, Tran TQ, Hsieh SC, Roedder S, Damm I, Vincenti F, Sarwal MM. A Computational Gene Expression Score for Predicting Immune Injury in Renal Allografts. PloS one 2015. PMID: 26367000


  62. Vincenti F, Silva HT, Busque S, O'Connell PJ, Russ G, Budde K, Yoshida A, Tortorici MA, Lamba M, Lawendy N, Wang W, Chan G. Evaluation of the effect of tofacitinib exposure on outcomes in kidney transplant patients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2015. PMID: 25649117


  63. Roedder S, Sigdel T, Salomonis N, Hsieh S, Dai H, Bestard O, Metes D, Zeevi A, Zeevi A, Gritsch A, Cheeseman J, Macedo C, Peddy R, Medeiros M, Vincenti F, Asher N, Salvatierra O, Shapiro R, Kirk A, Reed EF, Reed E, Sarwal MM. The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study. PLoS medicine 2014. PMID: 25386950


  64. Fiorina P, Vergani A, Bassi R, Niewczas MA, Altintas MM, Pezzolesi MG, D'Addio F, Chin M, Tezza S, Ben Nasr M, Mattinzoli D, Ikehata M, Corradi D, Schumacher V, Buvall L, Yu CC, Chang JM, La Rosa S, Finzi G, Solini A, Vincenti F, Rastaldi MP, Reiser J, Krolewski AS, Mundel PH, Sayegh MH. Role of podocyte B7-1 in diabetic nephropathy. Journal of the American Society of Nephrology : JASN 2014. PMID: 24676639


  65. Chandran S, Vincenti F. Clinical aspects: focusing on key unique organ-specific issues of renal transplantation. Cold Spring Harbor perspectives in medicine 2014. PMID: 24370927


  66. Rostaing L, Vincenti F, Grinyó J, Rice KM, Bresnahan B, Steinberg S, Gang S, Gaite LE, Moal MC, Mondragón-Ramirez GA, Kothari J, Pupim L, Larsen CP. Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2013. PMID: 24047110


  67. Wojciechowski D, Vincenti F. Tofacitinib in kidney transplantation. Expert opinion on investigational drugs 2013. PMID: 23841583


  68. van Gelder T, Baan C, Vincenti F, Mannon RB. Report of the second joint meeting of ESOT and AST: current pipelines in biotech and pharma. Transplant international : official journal of the European Society for Organ Transplantation 2013. PMID: 23822608


  69. Vagefi PA, Qian JJ, Carlson DM, Aparici CM, Hirose R, Vincenti F, Wojciechowski D. Native renal function after combined liver-kidney transplant for type 1 hepatorenal syndrome: initial report on the use of postoperative Technetium-99 m-mercaptoacetyltriglycine scans. Transplant international : official journal of the European Society for Organ Transplantation 2013. PMID: 23384317


  70. Wojciechowski D, Chanda R, Chandran S, Lee B, Webber A, Macaraig M, Tomlanovich S, Vincenti F. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year. Transplantation 2012. PMID: 23060281


  71. Wojciechowski D, Vincenti F. Belatacept in kidney transplantation. Current opinion in organ transplantation 2012. PMID: 23044530


  72. Hirsch HH, Vincenti F, Friman S, Tuncer M, Citterio F, Wiecek A, Scheuermann EH, Klinger M, Russ G, Pescovitz MD, Prestele H. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012. PMID: 23137180


  73. Wojciechowski D, Vincenti F. Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update. Biologics : targets & therapy 2012. PMID: 23152668


  74. Tang Q, Leung J, Melli K, Lay K, Chuu EL, Liu W, Bluestone JA, Kang SM, Peddi VR, Vincenti F. Altered balance between effector T cells and FOXP3+ HELIOS+ regulatory T cells after thymoglobulin induction in kidney transplant recipients. Transplant international : official journal of the European Society for Organ Transplantation 2012. PMID: 22994802


  75. Grinyo J, Alberu J, Contieri FL, Manfro RC, Mondragon G, Nainan G, Rial Mdel C, Steinberg S, Vincenti F, Dong Y, Thomas D, Kamar N. Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study. Transplant international : official journal of the European Society for Organ Transplantation 2012. PMID: 22816557


  76. Vincenti F, Tedesco Silva H, Busque S, O'Connell P, Friedewald J, Cibrik D, Budde K, Yoshida A, Cohney S, Weimar W, Kim YS, Lawendy N, Lan SP, Kudlacz E, Krishnaswami S, Chan G. Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012. PMID: 22682022


  77. Vincenti F. Are calcineurin inhibitors-free regimens ready for prime time? Kidney international 2012. PMID: 22622502


  78. Vincenti F. Beyond belatacept: praise and progress for the FDA. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012. PMID: 22335245


  79. Wojciechowski D, Vincenti F. Targeting JAK3 in kidney transplantation: current status and future options. Current opinion in organ transplantation 2011. PMID: 21971513


  80. Jen KY, Nguyen TB, Vincenti FG, Laszik ZG. C4d/CD34 double-immunofluorescence staining of renal allograft biopsies for assessing peritubular capillary C4d positivity. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011. PMID: 22037262


  81. Vincenti F, Larsen CP, Alberu J, Bresnahan B, Garcia VD, Kothari J, Lang P, Urrea EM, Massari P, Mondragon-Ramirez G, Reyes-Acevedo R, Rice K, Rostaing L, Steinberg S, Xing J, Agarwal M, Harler MB, Charpentier B. Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2011. PMID: 21992533


  82. Rostaing L, Neumayer HH, Reyes-Acevedo R, Bresnahan B, Florman S, Vitko S, Heifets M, Xing J, Thomas D, Vincenti F. Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetes. Clinical journal of the American Society of Nephrology : CJASN 2011. PMID: 21921152


  83. Vincenti F, Dritselis A, Kirkpatrick P. Belatacept. Nature reviews. Drug discovery 2011. PMID: 21878974


  84. Wojciechowski D, Vincenti F. Challenges and opportunities in targeting the costimulation pathway in solid organ transplantation. Seminars in immunology 2011. PMID: 21856169


  85. Webber A, Hirose R, Vincenti F. Novel strategies in immunosuppression: issues in perspective. Transplantation 2011. PMID: 21412186


  86. Vanrenterghem Y, Bresnahan B, Campistol J, Durrbach A, Grinyó J, Neumayer HH, Lang P, Larsen CP, Mancilla-Urrea E, Pestana JM, Block A, Duan T, Glicklich A, Gujrathi S, Vincenti F. Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies). Transplantation 2011. PMID: 21372756


  87. Friman S, Arns W, Nashan B, Vincenti F, Banas B, Budde K, Cibrik D, Chan L, Klempnauer J, Mulgaonkar S, Nicholson M, Wahlberg J, Wissing KM, Abrams K, Witte S, Woodle ES. Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2011. PMID: 21564523


  88. Trachtman H, Fervenza FC, Gipson DS, Heering P, Jayne DR, Peters H, Rota S, Remuzzi G, Rump LC, Sellin LK, Heaton JP, Streisand JB, Hard ML, Ledbetter SR, Vincenti F. A phase 1, single-dose study of fresolimumab, an anti-TGF-ß antibody, in treatment-resistant primary focal segmental glomerulosclerosis. Kidney international 2011. PMID: 21368745


  89. Humar A, Peeters P, Abramowicz D, Humar A, Lebranchu Y, Hauser I, Jardine A, Limaye AP, Vincenti F, Punch JD, Blumberg E. Response to questions regarding the design and results of the IMPACT trial. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2011. PMID: 21199360


  90. Grinyó J, Charpentier B, Pestana JM, Vanrenterghem Y, Vincenti F, Reyes-Acevedo R, Apanovitch AM, Gujrathi S, Agarwal M, Thomas D, Larsen CP. An integrated safety profile analysis of belatacept in kidney transplant recipients. Transplantation 2010. PMID: 21088650


  91. Larsen CP, Grinyó J, Medina-Pestana J, Vanrenterghem Y, Vincenti F, Breshahan B, Campistol JM, Florman S, Rial Mdel C, Kamar N, Block A, Di Russo G, Lin CS, Garg P, Charpentier B. Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies. Transplantation 2010. PMID: 21076381


  92. Humar A, Limaye AP, Blumberg EA, Hauser IA, Vincenti F, Jardine AG, Abramowicz D, Ives JA, Farhan M, Peeters P. Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study. Transplantation 2010. PMID: 21197713


  93. Posselt AM, Szot GL, Frassetto LA, Masharani U, Tavakol M, Amin R, McElroy J, Ramos MD, Kerlan RK, Fong L, Vincenti F, Bluestone JA, Stock PG. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade. Transplantation 2010. PMID: 20978464


  94. Wojciechowski D, Vincenti F. How the development of new biological agents may help minimize immunosuppression in kidney transplantation: the impact of belatacept. Current opinion in organ transplantation 2010. PMID: 20930638


  95. Ferguson R, Grinyó J, Vincenti F, Kaufman DB, Woodle ES, Marder BA, Citterio F, Marks WH, Agarwal M, Wu D, Dong Y, Garg P. Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010. PMID: 21114656


  96. Rostaing L, Massari P, Garcia VD, Mancilla-Urrea E, Nainan G, del Carmen Rial M, Steinberg S, Vincenti F, Shi R, Di Russo G, Thomas D, Grinyó J. Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study. Clinical journal of the American Society of Nephrology : CJASN 2010. PMID: 21051752


  97. Kuo HT, Sampaio MS, Vincenti F, Bunnapradist S. Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database. American journal of kidney diseases : the official journal of the National Kidney Foundation 2010. PMID: 20934793


  98. Posselt AM, Bellin MD, Tavakol M, Szot GL, Frassetto LA, Masharani U, Kerlan RK, Fong L, Vincenti FG, Hering BJ, Bluestone JA, Stock PG. Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010. PMID: 20659093


  99. Vincenti F, Blancho G, Durrbach A, Friend P, Grinyo J, Halloran PF, Klempnauer J, Lang P, Larsen CP, Mühlbacher F, Nashan B, Soulillou JP, Vanrenterghem Y, Wekerle T, Agarwal M, Gujrathi S, Shen J, Shi R, Townsend R, Charpentier B. Five-year safety and efficacy of belatacept in renal transplantation. Journal of the American Society of Nephrology : JASN 2010. PMID: 20634298


  100. Humar A, Lebranchu Y, Vincenti F, Blumberg EA, Punch JD, Limaye AP, Abramowicz D, Jardine AG, Voulgari AT, Ives J, Hauser IA, Peeters P. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010. PMID: 20353469


  101. Durrbach A, Pestana JM, Pearson T, Vincenti F, Garcia VD, Campistol J, Rial Mdel C, Florman S, Block A, Di Russo G, Xing J, Garg P, Grinyó J. A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010. PMID: 20415898


  102. Vincenti F, Charpentier B, Vanrenterghem Y, Rostaing L, Bresnahan B, Darji P, Massari P, Mondragon-Ramirez GA, Agarwal M, Di Russo G, Lin CS, Garg P, Larsen CP. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010. PMID: 20415897


  103. Wojciechowski D, Hirose R, Stock P, Vincenti F, Baxter-Lowe LA, Salvatierra O. Kidney transplantation at UCSF: 8,300 transplants and onward. Clinical transplants 2010. PMID: 21696039


  104. Vincenti F, Cohen SD, Appel G. Novel B cell therapeutic targets in transplantation and immune-mediated glomerular diseases. Clinical journal of the American Society of Nephrology : CJASN 2009. PMID: 20007678


  105. Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, Kreis HA, McDonald RA, Newmann JM, Obrador GT, Vincenti FG, Cheung M, Earley A, Raman G, Abariga S, Wagner M, Balk EM. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney international 2009. PMID: 19847156


  106. Busque S, Leventhal J, Brennan DC, Steinberg S, Klintmalm G, Shah T, Mulgaonkar S, Bromberg JS, Vincenti F, Hariharan S, Slakey D, Peddi VR, Fisher RA, Lawendy N, Wang C, Chan G. Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009. PMID: 19660021


  107. Yabu JM, Vincenti F. Kidney transplantation: the ideal immunosuppression regimen. Advances in chronic kidney disease 2009. PMID: 19576552


  108. Bunnapradist S, Vincenti F. Transplantation: To convert or not to convert: lessons from the CONVERT trial. Nature reviews. Nephrology 2009. PMID: 19556993


  109. Murphy B, Vincenti F, Meier-Kriesche HU. The AST's perspective on the proposed kidney allocation system. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009. PMID: 19459789


  110. Ekberg H, Mamelok RD, Pearson TC, Vincenti F, Tedesco-Silva H, Daloze P. The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony study. Transplantation 2009. PMID: 19424036


  111. Tavakol MM, Vincenti FG, Assadi H, Frederick MJ, Tomlanovich SJ, Roberts JP, Posselt AM. Long-term renal function and cardiovascular disease risk in obese kidney donors. Clinical journal of the American Society of Nephrology : CJASN 2009. PMID: 19443625


  112. Arias M, Campistol JM, Vincenti F. Evolving trends in induction therapy. Transplantation reviews (Orlando, Fla.) 2009. PMID: 19298940


  113. Latek R, Fleener C, Lamian V, Kulbokas E, Davis PM, Suchard SJ, Curran M, Vincenti F, Townsend R. Assessment of belatacept-mediated costimulation blockade through evaluation of CD80/86-receptor saturation. Transplantation 2009. PMID: 19300198


  114. Kuypers DR, Ekberg H, Grinyó J, Nashan B, Vincenti F, Snell P, Mamelok RD, Bouw RM. Mycophenolic acid exposure after administration of mycophenolate mofetil in the presence and absence of cyclosporin in renal transplant recipients. Clinical pharmacokinetics 2009. PMID: 19566116


  115. Bluestone JA, Liu W, Yabu JM, Laszik ZG, Putnam A, Belingheri M, Gross DM, Townsend RM, Vincenti F. The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008. PMID: 18828769


  116. Vincenti F, Kirk AD. What's next in the pipeline. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008. PMID: 18828764


  117. Halloran PF, Bromberg J, Kaplan B, Vincenti F. Tolerance versus immunosuppression: a perspective. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008. PMID: 18557737


  118. Grinyó J, Vanrenterghem Y, Nashan B, Vincenti F, Ekberg H, Lindpaintner K, Rashford M, Nasmyth-Miller C, Voulgari A, Spleiss O, Truman M, Essioux L. Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transplant international : official journal of the European Society for Organ Transplantation 2008. PMID: 18444945


  119. Vincenti F, Klintmalm G, Halloran PF. Open letter to the FDA: new drug trials must be relevant. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008. PMID: 18324977


  120. Vincenti F, Schena FP, Paraskevas S, Hauser IA, Walker RG, Grinyo J. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008. PMID: 18211506


  121. Vincenti F. Costimulation blockade in autoimmunity and transplantation. The Journal of allergy and clinical immunology 2008. PMID: 18269922


  122. Ekberg H, Grinyo J, Nashan B, Vanrenterghem Y, Vincenti F, Voulgari A, Truman M, Nasmyth-Miller C, Rashford M, CAESAR study group. Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The CAESAR Study. Am J Transplant 7, 560-570, 2007. Clinical journal of the American Society of Nephrology : CJASN 2008. PMID: 37001118


  123. Candiano G, Musante L, Petretto A, Bruschi M, Santucci L, Urbani A, Scolari F, Gusmano R, Carraro M, Zennaro C, Vincenti F, Ghiggeri GM. Proteomics of plasma and urine in primary nephrotic syndrome in children. Contributions to nephrology 2008. PMID: 18401158


  124. Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Viecek A, Chadban S, El-Shahawy M, Budde K, Goto N, DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C2 Monitoring Versus Tacrolimus) inve. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 7 1506-1514, 2007. Clinical journal of the American Society of Nephrology : CJASN 2008. PMID: 37001057


  125. Yabu JM, Ho B, Scandling JD, Vincenti F. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007. PMID: 17979998


  126. Vincenti F, Mendez R, Pescovitz M, Rajagopalan PR, Wilkinson AH, Butt K, Laskow D, Slakey DP, Lorber MI, Garg JP, Garovoy M. A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007. PMID: 17564637


  127. Yabu JM, Vincenti F. Novel immunosuppression: small molecules and biologics. Seminars in nephrology 2007. PMID: 17616278


  128. Pescovitz MD, Vincenti F, Hart M, Melton L, Whelchel J, Mulgaonkar S, McKay D, Leung M, Calleja E, Bouw MR. Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients. British journal of clinical pharmacology 2007. PMID: 17555465


  129. Vincenti F. Costimulation blockade--what will the future bring? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007. PMID: 17460033


  130. Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Wiecek A, Chadban S, El-Shahawy M, Budde K, Goto N. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007. PMID: 17359512


  131. Tomlanovich SJ, Vincenti F. Sirolimus: defining nephrotoxicity in the renal transplant recipient. Clinical journal of the American Society of Nephrology : CJASN 2007. PMID: 17699406


  132. Musante L, Candiano G, Petretto A, Bruschi M, Dimasi N, Caridi G, Pavone B, Del Boccio P, Galliano M, Urbani A, Scolari F, Vincenti F, Ghiggeri GM. Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. Journal of the American Society of Nephrology : JASN 2007. PMID: 17287427


  133. Ekberg H, Grinyó J, Nashan B, Vanrenterghem Y, Vincenti F, Voulgari A, Truman M, Nasmyth-Miller C, Rashford M. Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007. PMID: 17229079


  134. Vincenti F, Luggen M. T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation. Annual review of medicine 2007. PMID: 17020493


  135. Arns W, Cibrik DM, Walker RG, Mourad G, Budde K, Mueller EA, Vincenti F. Therapeutic drug monitoring of mycophenolic acid in solid organ transplant patients treated with mycophenolate mofetil: review of the literature. Transplantation 2006. PMID: 17060847


  136. Brennan TV, Fuller TF, Vincenti F, Chan S, Chang CK, Bostrom A, Zlatunich JK, Tomlanovich SJ, Feng S. Living donor kidney transplant recipients and clinical trials: participation profiles and impact on post-transplant care. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006. PMID: 16925565


  137. Hirose R, Vincenti F. Immunosuppression: today, tomorrow, and withdrawal. Seminars in liver disease 2006. PMID: 16850369


  138. Vincenti F, de Andrés A, Becker T, Choukroun G, Cole E, González-Posada JM, Kumar MA, Moore R, Nadalin S, Nashan B, Rostaing L, Saito K, Yoshimura N. Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients. Transplant international : official journal of the European Society for Organ Transplantation 2006. PMID: 16771865


  139. Vincenti F. Antibodies come back to the forefront in transplantation. Clinical journal of the American Society of Nephrology : CJASN 2006. PMID: 17699237


  140. Vincenti F, Mendez R, Curtis J, Light J, Pearson T, Wu YM, Katz SM, Akalin E, Esterl R, Gugliuzza K, Shihab F, Jordan S, Jonsson J, Molmenti E, Barbeito R. A multicenter, prospective study of C2-monitored cyclosporine microemulsion in a U.S. population of de novo renal transplant recipients. Transplantation 2005. PMID: 16249738


  141. Land W, Vincenti F. Toxicity-sparing protocols using mycophenolate mofetil in renal transplantation. Transplantation 2005. PMID: 16251855


  142. Vincenti F. Current use and future trends in induction therapy. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2005. PMID: 18202505


  143. Aziz S, Callen PW, Vincenti F, Hirose R. Rapidly developing nephrocalcinosis in a patient with end-stage liver disease who received a domino liver transplant from a patient with known congenital oxalosis. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2005. PMID: 16179633


  144. Vincenti F, Larsen C, Durrbach A, Wekerle T, Nashan B, Blancho G, Lang P, Grinyo J, Halloran PF, Solez K, Hagerty D, Levy E, Zhou W, Natarajan K, Charpentier B. Costimulation blockade with belatacept in renal transplantation. The New England journal of medicine 2005. PMID: 16120857


  145. Vincenti F. A drug of the past, a lesson for the future. Pediatric transplantation 2005. PMID: 15910379


  146. Wilkinson A, Davidson J, Dotta F, Home PD, Keown P, Kiberd B, Jardine A, Levitt N, Marchetti P, Markell M, Naicker S, O'Connell P, Schnitzler M, Standl E, Torregosa JV, Uchida K, Valantine H, Villamil F, Vincenti F, Wissing M. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clinical transplantation 2005. PMID: 15877787


  147. Vincenti F, Ghiggeri GM. New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005. PMID: 15888021


  148. Vincenti F, Tuncer M, Castagneto M, Klinger M, Friman S, Scheuermann EH, Wiecek A, Russ GR, Martinek A, Nonnast-Daniel B. Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation. Transplantation proceedings 2005. PMID: 15848604


  149. Peddi VR, Jensik S, Pescovitz M, Pirsch J, Adler SH, Thistlethwaite JR, Vincenti F, Cohen DJ. An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency. Clinical transplantation 2005. PMID: 15659146


  150. Vincenti F, Rostaing L. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation. Contemporary clinical trials 2005. PMID: 15837449


  151. Woodle ES, Vincenti F, Lorber MI, Gritsch HA, Hricik D, Washburn K, Matas AJ, Gallichio M, Neylan J. A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005. PMID: 15636625


  152. Vincenti F. Chronic induction. What's new in the pipeline. Contributions to nephrology 2005. PMID: 15567917


  153. Lipshutz GS, Flechner SM, Govani MV, Vincenti F. BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004. PMID: 15575919


  154. Vincenti F. Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients. Transplant international : official journal of the European Society for Organ Transplantation 2004. PMID: 15365604


  155. Armuzzi A, De Pascalis B, Lupascu A, Fedeli P, Leo D, Mentella MC, Vincenti F, Melina D, Gasbarrini G, Pola P, Gasbarrini A. Infliximab in the treatment of steroid-dependent ulcerative colitis. European review for medical and pharmacological sciences 2004. PMID: 15638236


  156. Vincenti F. A decade of progress in kidney transplantation. Transplantation 2004. PMID: 15201687


  157. Ghiggeri GM, Carraro M, Vincenti F. Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004. PMID: 15004256


  158. Vincenti F, Brennan TV, Fuller TF, Feng S. Optimizing the use of cyclosporine (Neoral) for recipients of living donor kidneys. Transplantation proceedings 2004. PMID: 15041306


  159. Ramos E, Vincenti F, Lu WX, Shapiro R, Trofe J, Stratta RJ, Jonsson J, Randhawa PS, Drachenberg CB, Papadimitriou JC, Weir MR, Wali RK. Retransplantation in patients with graft loss caused by polyoma virus nephropathy. Transplantation 2004. PMID: 14724448


  160. Pescovitz MD, Bumgardner G, Gaston RS, Kirkman RL, Light S, Patel IH, Nieforth K, Vincenti F. Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporine and steroids in renal transplantation. Clinical transplantation 2003. PMID: 14756266


  161. Posselt AM, Vincenti F, Bedolli M, Lantz M, Roberts JP, Hirose R. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients. Transplantation 2003. PMID: 12865808


  162. Vincenti F. Immunosuppression minimization: current and future trends in transplant immunosuppression. Journal of the American Society of Nephrology : JASN 2003. PMID: 12819255


  163. Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, Kliem V, Legendre C, Morais Sarmento AL, Vincenti F. Prevalence and management of anemia in renal transplant recipients: a European survey. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003. PMID: 12814475


  164. Vincenti F, Stock P. De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco. Transplantation proceedings 2003. PMID: 12742494


  165. Vincenti F, Monaco A, Grinyo J, Kinkhabwala M, Roza A. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003. PMID: 12614286


  166. Vincenti F. New monoclonal antibodies in renal transplantation. Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2003. PMID: 12773967


  167. Vincenti F, Pace D, Birnbaum J, Lantz M. Pharmacokinetic and pharmacodynamic studies of one or two doses of daclizumab in renal transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003. PMID: 12492710


  168. Vincenti F. What's in the pipeline? New immunosuppressive drugs in transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2002. PMID: 12482141


  169. Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation 2002. PMID: 11907427


  170. Parasrampuria DA, Lantz MV, Birnbaum JL, Vincenti FG, Benet LZ. Effect of calcineurin inhibitor therapy on P-gp expression and function in lymphocytes of renal transplant patients: a preliminary evaluation. Volume 42 of Issue 3. Journal of clinical pharmacology 2002. PMID: 11865967


  171. Vincenti F. Interleukin-2 receptor monoclonal antibodies in renal transplantation: current use and emerging regimens. Transplantation proceedings 2001. PMID: 11750360


  172. Bumgardner GL, Hardie I, Johnson RW, Lin A, Nashan B, Pescovitz MD, Ramos E, Vincenti F, Phase III Daclizumab Study Group. Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation. Transplantation 2001. PMID: 11571447


  173. Bumgardner GL, Ramos E, Lin A, Vincenti F. Daclizumab (humanized anti-IL2Ralpha mAb) prophylaxis for prevention of acute rejection in renal transplant recipients with delayed graft function. Transplantation 2001. PMID: 11544424


  174. Vincenti F. Is complete avoidance of calcineurin inhibitors or steroids now possible? Importance of patient selection and choice of regimen. Transplantation proceedings 2001. PMID: 11406263


  175. Vincenti F, Ramos E, Brattstrom C, Cho S, Ekberg H, Grinyo J, Johnson R, Kuypers D, Stuart F, Khanna A, Navarro M, Nashan B. Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation. Transplantation 2001. PMID: 11397963


  176. Vincenti F, Monaco A, Grinyo J, Kinkhabwala M, Neylan J, Roza A, Somberg K. Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation. Transplantation proceedings 2001. PMID: 11267168


  177. Vincenti F. Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial. Transplantation proceedings 2001. PMID: 11267172


  178. Vincenti F. The role of newer monoclonal antibodies in renal transplantation. Transplantation proceedings 2001. PMID: 11267163


  179. Norman DJ, Vincenti F, de Mattos AM, Barry JM, Levitt DJ, Wedel NI, Maia M, Light SE. Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors. Transplantation 2000. PMID: 11152101


  180. Chang GJ, Mahanty HD, Vincenti F, Freise CE, Roberts JP, Ascher NL, Stock PG, Hirose R. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function. Clinical transplantation 2000. PMID: 11127307


  181. Pirsch J, Bekersky I, Vincenti F, Boswell G, Woodle ES, Alak A, Kruelle M, Fass N, Facklam D, Mekki Q. Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: pharmacokinetics and tolerability. Journal of clinical pharmacology 2000. PMID: 10806606


  182. Korsun A, Vincenti F, Ruck D, Whitelaw N, Ladoulis C, Whitelaw G. The role of daclizumab in balancing resources for inpatient and outpatient transplant services. Progress in transplantation (Aliso Viejo, Calif.) 2000. PMID: 10941323


  183. Ekberg H, Bäckman L, Tufveson G, Tydén G, Nashan B, Vincenti F. Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis. Transplant international : official journal of the European Society for Organ Transplantation 2000. PMID: 10836653


  184. Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz CJ, Roza AM, Vincenti F, George V. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation 1999. PMID: 10507481


  185. Vincenti F. Daclizumab: novel biologic immunoprophylaxis for prevention of acute rejection in renal transplantation. Transplantation proceedings 1999. PMID: 10500546


  186. Vincenti F. Potential of daclizumab in solid organ transplantation. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1999. PMID: 18031143


  187. Vincenti F, Grinyo J, Ramos E, Nashan B, Stuart F, Kuypers D, Brattstrom C, Cho S, Ekberg H, Johnson R. Can antibody prophylaxis allow sparing of other immunosuppressives? Transplantation proceedings 1999. PMID: 10083557


  188. Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz C, Roza AM, Vincenti F, George V. Recurrent and de novo glomerular disease after renal transplantation: a report from renal allograft disease registry. Transplantation proceedings 1999. PMID: 10083084


  189. Hirose R, Vincenti F. Review of transplantation--1999. Clinical transplants 1999. PMID: 11038649


  190. Solez K, Vincenti F, Filo RS. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation 1998. PMID: 9884269


  191. Vincenti F, Nashan B, Light S. Daclizumab: outcome of phase III trials and mechanism of action. Double Therapy and the Triple Therapy Study Groups. Transplantation proceedings 1998. PMID: 9723424


  192. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG. Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation 1998. PMID: 9583865


  193. Vincenti F, Kirkman R, Light S, Bumgardner G, Pescovitz M, Halloran P, Neylan J, Wilkinson A, Ekberg H, Gaston R, Backman L, Burdick J. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. The New England journal of medicine 1998. PMID: 9428817


  194. Bretan PN, Freise C, Goldstein R, Osorio R, Tomlanovich S, Amend W, Mathur V, Vincenti F. Selection strategies for successful utilization of less than 15.kg pediatric donor kidneys. Transplantation proceedings 1997. PMID: 9414712


  195. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997. PMID: 9112351


  196. Miller J, Pirsch JD, Deierhoi M, Vincenti F, Filo RS. FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group. Transplantation proceedings 1997. PMID: 9123008


  197. Bretan PN, Friese C, Goldstein RB, Osorio RW, Tomlanovich S, Amend W, Mathur V, Vincenti F. Immunologic and patient selection strategies for successful utilization of less than 15 kg pediatric donor kidneys--long term experiences with 40 transplants. Transplantation 1997. PMID: 9020323


  198. Vincenti F, Lantz M, Birnbaum J, Garovoy M, Mould D, Hakimi J, Nieforth K, Light S. A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation. Transplantation 1997. PMID: 9000657


  199. Laskow DA, Vincenti F, Neylan JF, Mendez R, Matas AJ. An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. Transplantation 1996. PMID: 8878381


  200. Woodle ES, Thistlethwaite JR, Gordon JH, Laskow D, Deierhoi MH, Burdick J, Pirsch JD, Sollinger H, Vincenti F, Burrows L, Schwartz B, Danovitch GM, Wilkinson AH, Shaffer D, Simpson MA, Freeman RB, Rohrer RJ, Mendez R, Aswad S, Munn SR, Wiesner RH, Delmonico FL, Neylan J, Whelchel J. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. Transplantation 1996. PMID: 8830821


  201. Vincenti F, Laskow DA, Neylan JF, Mendez R, Matas AJ. One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group. Transplantation 1996. PMID: 8669100


  202. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. The New England journal of medicine 1996. PMID: 8596570


  203. Stock PG, Lantz M, Light S, Vincenti F. In vivo (phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients. Transplantation proceedings 1996. PMID: 8623460


  204. Vincenti F, Danovitch GM, Neylan JF, Steiner RW, Everson MP, Gaston RS. Pentoxifylline does not prevent the cytokine-induced first dose reaction following OKT3--a randomized, double-blind placebo-controlled study. Transplantation 1996. PMID: 8610383


  205. Lam PW, Wachs ME, Somberg KA, Vincenti F, Lake JR, Ferrell LD. Fibrosing cholestatic hepatitis in renal transplant recipients. Transplantation 1996. PMID: 8610344


  206. Sorof JM, Vartanian RK, Olson JL, Tomlanovich SJ, Vincenti FG, Amend WJ. Histopathological concordance of paired renal allograft biopsy cores. Effect on the diagnosis and management of acute rejection. Transplantation 1995. PMID: 8525513


  207. Orloff SL, Stempel CA, Wright TL, Tomlanovich SJ, Amend WJ, Stock PG, Melzer JS, Vincenti F. Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection. Clinical transplantation 1995. PMID: 7599400


  208. Laskow DA, Vincenti F, Neylan J, Mendez R, Matas A. Phase II FK 506 multicenter concentration control study: one-year follow-up. Transplantation proceedings 1995. PMID: 7533431


  209. Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation 1995. PMID: 7839446


  210. Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. American journal of kidney diseases : the official journal of the National Kidney Foundation 1994. PMID: 8154495


  211. Vincenti FG, Vasconcelos M, Birnbaum JL, Tomlanovich SJ, Amend WJ, Melzer JS, Snyder JP. Pentoxifylline reduces the first-dose reactions following OKT3. Transplantation proceedings 1993. PMID: 8465428


  212. Vincenti F, Lake J, Wright T, Kuo G, Weber P, Stempel C. Nontransmission of hepatitis C from cadaver kidney donors to transplant recipients. Transplantation 1993. PMID: 7681231


  213. Stempel CA, Lake J, Kuo G, Vincenti F. Hepatitis C--its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993. PMID: 7679527


  214. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F. Recurrent focal glomerulosclerosis: natural history and response to therapy. The American journal of medicine 1992. PMID: 1558084


  215. Krams SM, Falco DA, Villanueva JC, Rabkin J, Tomlanovich SJ, Vincenti F, Amend WJ, Melzer J, Garovoy MR, Roberts JP. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation 1992. PMID: 1733064


  216. Vincenti F, Weber P, Kuo G, Forsell J, Hunt S, Melzer J, Salvatierra O, Stempel C. Hepatitis C virus in cadaver organ donors: prevalence and risk of transmission to transplant recipients. Transplantation proceedings 1991. PMID: 1656566


  217. Stempel C, Lake J, Ferrell L, Tomlanovich S, Amend W, Salvatierra O, Vincenti F. Effect of cyclosporine on the clinical course of HBsAg-positive renal transplant patients. Transplantation proceedings 1991. PMID: 1989202


  218. Salvatierra O, McVicar J, Melzer J, Amend W, Vincenti F, Tomlanovich S, Husing R, Rabkin J, Garovoy M. Improved results with combined donor-specific transfusion (DST) and sequential therapy protocol. Transplantation proceedings 1991. PMID: 1989146


  219. Vincenti F, Biava C, Tomlanovitch S, Amend WJ, Garovoy M, Melzer J, Feduska N, Salvatierra O. Inability of cyclosporine to completely prevent the recurrence of focal glomerulosclerosis after kidney transplantation. Transplantation 1989. PMID: 2650043


  220. Lockard-Marduel A, Gumbert M, Tomlanovich S, Amend W, Vincenti F, Schralla P, Melzer J, Feduska NJ, Salvatierra O, Garovoy MR. Immunologic alterations induced by donor-specific transfusion. Transplantation proceedings 1989. PMID: 2523120


  221. Melzer JS, Husing R, Lou C, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Salvatierra O. Successful management of the highly sensitized renal allograft recipient. Transplantation proceedings 1989. PMID: 2650256


  222. Tomlanovich SJ, Sabatte-Caspillo J, Melzer J, Amend W, Vincenti F, Feduska N, Salvatierra O. The incidence and impact of herpes simplex virus infections in the first month following renal transplantation. Transplantation proceedings 1989. PMID: 2652674


  223. Feduska NJ, Melzer JS, Amend WJ, Vincenti F, Tomlanovich SJ, Garovoy M, Husing R, Salvatierra O. Cyclosporine provides better success rates for both higher- and lower-risk cadaveric kidney transplant recipients. Transplantation proceedings 1988. PMID: 3291212


  224. Melzer JS, Husing RM, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Lou C, Salvatierra O. How to improve results for second renal allografts. Transplantation proceedings 1988. PMID: 3291238


  225. Tomlanovich S, Vincenti F, Amend W, Biava C, Melzer J, Feduska N, Salvatierra O. Is cyclosporine effective in preventing recurrence of immune-mediated glomerular disease after renal transplantation? Transplantation proceedings 1988. PMID: 3289209


  226. Hricak H, Terrier F, Marotti M, Engelstad BL, Filly RA, Vincenti F, Duca RM, Bretan PN, Higgins CB, Feduska N. Posttransplant renal rejection: comparison of quantitative scintigraphy, US, and MR imaging. Radiology 1987. PMID: 3544032


  227. Salvatierra O, Melzer J, Vincenti F, Amend WJ, Tomlanovich S, Potter D, Husing R, Garovoy M, Feduska NJ. Donor-specific blood transfusions versus cyclosporine--the DST story. Transplantation proceedings 1987. PMID: 3547813


  228. Melzer JS, Husing RM, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Salvatierra O. Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence? Transplantation proceedings 1987. PMID: 2856274


  229. Feduska NJ, Perkins HA, Melzer J, Amend WJ, Vincenti F, Tomlanovich S, Garovoy M, Salvatierra O. Observations relating to the incidence of the acquired immune deficiency syndrome and other possibly associated conditions in a large population of renal transplant recipients. Transplantation proceedings 1987. PMID: 3547917


  230. Linkowski GD, Warvariv V, Filly RA, Vincenti F. Sonography in the diagnosis of acute renal allograft rejection and cyclosporine nephrotoxicity. AJR. American journal of roentgenology 1987. PMID: 3541547


  231. Melzer JS, Husing RM, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Salvatierra O. The beneficial effect of pretransplant blood transfusions in cyclosporine-treated cadaver renal allograft recipients. Transplantation 1987. PMID: 3541325


  232. Hoddick W, Filly RA, Backman U, Callen PW, Vincenti F, Hricak H, Mahony BS, Amend W. Renal allograft rejection: US evaluation. Radiology 1986. PMID: 3532192


  233. Bachman U, Biava C, Amend W, Feduska N, Melzer J, Salvatierra O, Vincenti F. The clinical course of IgA-nephropathy and Henoch-Schönlein purpura following renal transplantation. Transplantation 1986. PMID: 3538537


  234. Feduska NJ, Melzer J, Amend WJ, Vincenti F, Tomlanovich S, Salvatierra O. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months. Transplantation proceedings 1986. PMID: 3515681


  235. Stabile C, Vincenti F, Garovoy M, Duca R, Melzer J, Feduska NJ, Salvatierra O, Amend WJ. Is a "low" dose of prednisone better than a "high" dose at the time of renal transplantation? Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 1986. PMID: 3297218


  236. Salvatierra O, Melzer J, Potter D, Garovoy M, Vincenti F, Amend WJ, Husing R, Hopper S, Feduska NJ. A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacy. Transplantation 1985. PMID: 3907038


  237. Shermantine M, Gambertoglio J, Amend W, Vincenti F, Oie S. Pharmacokinetics of sulfisoxazole in renal transplant patients. Antimicrobial agents and chemotherapy 1985. PMID: 3907496


  238. Feduska NJ, Melzer J, Amend W, Vincenti F, Duca R, Garovoy M, Hopper S, Salvatierra O. Dramatic improvement in the success rate for renal transplants in diabetic recipients with donor-specific transfusions. Transplantation 1984. PMID: 6390836


  239. Feduska NJ, Amend WJ, Vincenti F, Melzer JS, Duca R, Garovoy MR, Salvatierra O. Peptic ulcer disease in kidney transplant recipients. American journal of surgery 1984. PMID: 6377938


  240. Vincenti F, Arnaud SB, Recker R, Genant H, Amend WJ, Feduska NJ, Salvatierra O. Parathyroid and bone response of the diabetic patient to uremia. Kidney international 1984. PMID: 6482171


  241. Vincenti F, Amend WJ, Kaysen G, Feduska N, Birnbaum J, Duca R, Salvatierra O. Long-term renal function in kidney donors. Sustained compensatory hyperfiltration with no adverse effects. Transplantation 1983. PMID: 6659058


  242. Salvatierra O, Vincenti F, Amend WJ, Garovoy MR, Potter D, Feduska NJ. The role of blood transfusions in renal transplantation. The Urologic clinics of North America 1983. PMID: 6190285


  243. Berger BE, Vincenti F, Biava C, Amend WJ, Feduska N, Salvatierra O. De novo and recurrent membranous glomerulopathy following kidney transplantation. Transplantation 1983. PMID: 6340284


  244. Benet LZ, Smith DE, Lin ET, Vincenti F, Gambertoglio JG. Furosemide assays and disposition in healthy volunteers and renal transplant patients. Federation proceedings 1983. PMID: 6339277


  245. O'Connor DT, Barg AP, Amend W, Vincenti F. Urinary kallikrein excretion after renal transplantation: relationship to hypertension, graft source, and renal function. The American journal of medicine 1982. PMID: 6751083


  246. Feduska NJ, Amend WJ, Vincenti F, Duca R, Salvatierra O. Blood transfusions before and on the day of transplantation: effects on cadaver graft survival. Transplantation proceedings 1982. PMID: 7051470


  247. Salvatierra O, Iwaki Y, Vincenti F, Amend W, Terasaki P, Garovoy M, Duca R, Hopper S, Feduska N. Update of the University of California at San Francisco experience with donor-specific blood transfusions. Transplantation proceedings 1982. PMID: 7051480


  248. Vincenti F, Amend WJ, Feduska NJ, Salvatierra O. Blood transfusions and kidney transplantation. Archives of internal medicine 1982. PMID: 6462121


  249. Gambertoglio JG, Frey FJ, Holford NH, Birnbaum JL, Lizak PS, Vincenti F, Feduska NJ, Salvatierra O, Amend WJ. Prednisone and prednisolone bioavailability in renal transplant patients. Kidney international 1982. PMID: 7047863


  250. Amend WJ, Vincenti F, Duca R, Feduska NJ, Cochrum K, Potter D, Salvatierra O. Prognostic features of early renal transplant rejections. American journal of kidney diseases : the official journal of the National Kidney Foundation 1982. PMID: 7041637


  251. Vincenti F, Amend WJ, Feduska NJ, Salvatierra O. Septic arthritis following renal transplantation. Nephron 1982. PMID: 7048116


  252. Feduska NJ, Vincenti F, Amend W, Iwaki Y, Opelz G, Terasaki P, Duca R, Hopper S, Salvatierra O. An alternative to cadaver kidney transplants for patients with insulin-dependent diabetes mellitus. Transplantation 1981. PMID: 6461954


  253. Salvatierra O, Iwaki Y, Vincenti F, Amend W, Potter D, Opelz G, Terasaki P, Duca R, Hopper S, Feduska N. Incidence, characteristics, and outcome of recipients sensitized after donor-specific blood transfusions. Transplantation 1981. PMID: 7041356


  254. Cochrum K, Hanes D, Potter D, Perkins H, Amend W, Vincenti F, Iwaki Y, Opelz G, Terasaki P, Levin B, Sampson D, Feduska N, Salvatierra O. Improved graft survival following donor-specific blood transfusions. Transplantation proceedings 1981. PMID: 7029829


  255. Cogan MG, Sargent JA, Yarbrough SG, Vincenti F, Amend WJ. Prevention of prednisone-induced negative nitrogen balance. Effect of dietary modification on urea generation rate in patients on hemodialysis receiving high-dose glucocorticoids. Annals of internal medicine 1981. PMID: 7258863


  256. Salvatierra O, Amend W, Vincenti F, Potter D, Stoney R, Duca R, Feduska N. 1,500 renal transplants at one center: evolution of a strategy for optimal success. American journal of surgery 1981. PMID: 7020458


  257. Smith DE, Gambertoglio JG, Vincenti F, Benet LZ. Furosemide kinetics and dynamics after kidney transplant. Clinical pharmacology and therapeutics 1981. PMID: 7016396


  258. Amend WJ, Vincenti F, Feduska NJ, Salvatierra O, Johnston WH, Jackson J, Tilney N, Garovoy M, Burwell EL. Recurrent systemic lupus erythematosus involving renal allografts. Annals of internal medicine 1981. PMID: 7011137


  259. Vincenti F, Hattner R, Amend WJ, Feduska NJ, Duca RM, Salvatierra O. Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis. JAMA 1981. PMID: 7007680


  260. Feduska NJ, Amend WJ, Vincenti F, Perkins HA, Opelz G, Terasaki PI, Iwaki Y, Duca R, Dodge D, Salvatierra O. Graft survival with high levels of cytotoxic antibodies. Transplantation proceedings 1981. PMID: 7022910


  261. Cochrum K, Hanes D, Potter D, Perkins H, Amend W, Vincenti F, Iwaki Y, Opelz G, Terasaki P, Feduska N, Salvatierra O. Improved graft survival with donor-specific transfusion pretreatment. Transplantation proceedings 1981. PMID: 7022820


  262. Salvatierra O, Amend W, Vincenti F, Potter D, Iwaki Y, Opelz G, Terasaki P, Duca R, Hanes D, Cochrum KC, Hopper S, Feduska NJ. Pretreatment with donor-specific blood transfusions in related recipients with high MLC. Transplantation proceedings 1981. PMID: 6455788


  263. Gambertoglio JG, Vincenti F, Feduska NJ, Birnbaum J, Salvatierra O, Amend WJ. Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients. The Journal of clinical endocrinology and metabolism 1980. PMID: 6997330


  264. Vincenti F, Amend W, Feduska NJ, Duca RM, Salvatierra O. Improved outcome following renal transplantation with reduction in the immunosuppression therapy for rejection episodes. The American journal of medicine 1980. PMID: 6992574


  265. Vincenti F, Amend WJ, Abele J, Feduska NJ, Salvatierra O. The role of hypertension in hemodialysis-associated atherosclerosis. The American journal of medicine 1980. PMID: 6987872


  266. Pearson JC, Amend WJ, Vincenti FG, Feduska NJ, Salvatierra O. Post-transplantation pyelonephritis: factors producing low patient and transplant morbidity. The Journal of urology 1980. PMID: 6986476


  267. Salvatierra O, Vincenti F, Amend W, Potter D, Iwaki Y, Opelz G, Terasaki P, Duca R, Cochrum K, Hanes D, Stoney RJ, Feduska NJ. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Annals of surgery 1980. PMID: 6448588


  268. Hopper S, Feduska N, Vincenti F, Amend W, Salvatierra O. The organization of a successful donor-specific transfusion protocol in related recipients with high MLC. Proceedings of the Clinical Dialysis and Transplant Forum 1980. PMID: 6180431


  269. Cochrum KC, Hanes D, Potter D, Vincenti F, Amend W, Feduska N, Perkins H, Salvatierra O. Donor-specific blood transfusions in HLA-D-disparate one-haplotype-related allografts. Transplantation proceedings 1979. PMID: 161102


  270. Spring DB, Salvatierra O, Palubinskas AJ, Amend WJ, Vincenti FG, Feduska NJ. Results and significance of angiography in potential kidney donors. Radiology 1979. PMID: 382250


  271. Wolf JL, Perkins HA, Schreeder MT, Vincenti F. The transplanted kidney as a source of hepatitis B infection. Annals of internal medicine 1979. PMID: 382937


  272. Salvatierra O, Feduska NJ, Vincenti F, Duca R, Potter D, Nolan J, Cochrum KC, Amend WJ. Analysis of costs and outcomes of renal transplantation at one center. Its implications. JAMA 1979. PMID: 372589


  273. Feduska NJ, Collins GM, Amend WJ, Vincenti F, Duca RM, Stieper KW, Mitchell JW, Cochrum KC, Salvatierra O. Comparative study of albumin solution and cryoprecipitated plasma for renal preservation: a preliminary report. Transplantation proceedings 1979. PMID: 377678


  274. Cochrum K, Hanes D, Van Speybroeck J, Perkins H, Ferrone S, Indeveri F, Amend W, Vincenti F, Feduska N, Salvatierra O. HLA-D antigen disparity and HLA-DRw antibodies in intrafamilial renal allograft survival. Transplantation proceedings 1979. PMID: 156426


  275. Speybroeck JV, Feduska N, Amend W, Vincenti F, Cochrum K, Salvatierra O. The influence of donor age on graft survival. American journal of surgery 1979. PMID: 373476


  276. Feduska NJ, Vincenti F, Amend WJ, Duca R, Cochrum K, Salvatierra O. Do blood transfusions enhance the possibility of a compatible transplant? Transplantation 1979. PMID: 375493


  277. Vincenti F, Amend W, Feduska N, Duca R, Salvatierra O. Pretransplant cytotoxic antibodies do not segregate kidney transplant recipients into responder and non-responder groups. Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 1979. PMID: 398515


  278. Vincenti F, Duca RM, Amend W, Perkins HA, Cochrum KC, Feduska NJ, Salvatierra O. Immunologic factors determining survival of cadaver-kidney transplants. The effect of HLA serotyping, cytotoxic antibodies and blood transfusions on graft survival. The New England journal of medicine 1978. PMID: 151230


  279. Cochrum KC, Haynes DM, Salvatierra O, Feduska NJ, Vincenti F, Van Speybroeck J. Leukocyte migration inhibitory factor (LIF) as an indicator of presensitization and allograft survival. Transplantation proceedings 1978. PMID: 150081


  280. Feduska NJ, Belzer FO, Stieper KW, Duca RM, Mitchell JW, Vincenti F, Cochrum KC, Salvatierra O. A ten year experience with cadaver kidney preservation using cryoprecipitated plasma. American journal of surgery 1978. PMID: 343620


  281. Feduska NJ, Amend WJ, Vincenti F, Duca RM, Stieper KW, Mitchell JW, Cochrum KC, Salvatierra O. Cadaver kidney transplantation provided from one center within a large geographical region. Transactions - American Society for Artificial Internal Organs 1978. PMID: 362673


  282. Vincenti F, Amend W, Feduska N, Maglio M, Axel L, Cochrum K, Salvatierra O. The effect of hypothermic pulsatile perfusion on glomerular epithelial surface structures studied by scanning electron microscopy. Transactions - American Society for Artificial Internal Organs 1978. PMID: 716010


  283. Denes AE, Berquist KR, Fields HA, Vincenti F. Hepatitis-B reactivation after renal transplantation. Lancet (London, England) 1977. PMID: 68414


  284. Amend W, Vincenti F, Covey C, Epstein W, Feduska N, Salvatierra O. Renal transplantation in systemic lupus erythematosus. Proceedings of the Clinical Dialysis and Transplant Forum 1977. PMID: 356035


  285. Vincenti F, Birbari A, Rizk G. Renal vein renin in hypertension. Diagnostic and therapeutic implications. Le Journal medical libanais. The Lebanese medical journal 1973. PMID: 4718010


  286. Vincenti F, Hajjar ET, Salti IS. Tumorous hyperparathyroidism in hypophosphatemic vitamin D--resistant rickets. Le Journal medical libanais. The Lebanese medical journal 1973. PMID: 4361307